Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00684
|
|||||
| Drug Name |
Midazolam
|
|||||
| Synonyms |
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate; 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine; 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride; 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine; 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine; Dazolam; Dormicum; Dormicum (TN); Hypnovel (TN); Midacum (TN); Midanium; Midazolam (JAN/INN); Midazolam Base; Midazolam [INN:BAN:JAN]; Midazolamum; Midazolamum [INN-Latin]; Midosed; Ro 21-3981; Versed; Versed (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Seizure [ICD11: 8A68] | Approved | [1] | |||
| Therapeutic Class |
Hypnotics and Sedatives
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H13ClFN3
|
|||||
| Canonical SMILES |
CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
|
|||||
| InChI |
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
|
|||||
| InChIKey |
DDLIGBOFAVUZHB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 59467-70-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 325.8 | Topological Polar Surface Area | 30.2 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103189248
, 104305695
, 10528812
, 126628994
, 126644317
, 126685927
, 126723172
, 127718929
, 134337555
, 135006020
, 137003028
, 140030431
, 14850779
, 151981999
, 160964028
, 163414843
, 164763056
, 164814508
, 175265628
, 178100372
, 179116788
, 198991796
, 210279804
, 210282127
, 223440338
, 223675382
, 224544524
, 226421396
, 241102041
, 24724654
, 250117805
, 252088595
, 29223297
, 46507611
, 48416279
, 49689435
, 49833675
, 49978815
, 50113067
, 50371480
, 53789031
, 57322185
, 7433688
, 7847616
, 7849648
, 7979987
, 8152621
, 92716937
, 93166805
, 9727
|
|||||
| ChEBI ID |
CHEBI:6931
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Midazolam was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.